Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027

PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3934
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:100
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(オラパリブ、タラゾパリブ)、用途別市場規模(卵巣がん、乳がん、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・PARP(ポリADPリボースポリメラーゼ)阻害剤の市場動向
・企業の競争状況、市場シェア
・PARP(ポリADPリボースポリメラーゼ)阻害剤の種類別市場規模(オラパリブ、タラゾパリブ)
・PARP(ポリADPリボースポリメラーゼ)阻害剤の用途別市場規模(卵巣がん、乳がん、その他)
・PARP(ポリADPリボースポリメラーゼ)阻害剤の北米市場規模2016-2027(アメリカ、カナダ)
・PARP(ポリADPリボースポリメラーゼ)阻害剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・PARP(ポリADPリボースポリメラーゼ)阻害剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・PARP(ポリADPリボースポリメラーゼ)阻害剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・PARP(ポリADPリボースポリメラーゼ)阻害剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AbbVie、Pfizer、AstraZeneca、GlaxoSmithKline、Clovis Oncology、Everest Pharmaceuticals)
・結論

PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.

Market Analysis and Insights: Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market
The global PARP (Poly ADP-ribose Polymerase) Inhibitors market size is projected to reach US$ 21490 million by 2027, from US$ 2861 million in 2020, at a CAGR of 32.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PARP (Poly ADP-ribose Polymerase) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PARP (Poly ADP-ribose Polymerase) Inhibitors market.

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Scope and Market Size
PARP (Poly ADP-ribose Polymerase) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Olaparib
Talazoparib

Segment by Application
Ovarian Cancer
Breast Cancer
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Pfizer
AstraZeneca
GlaxoSmithKline
Clovis Oncology
Everest Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Olaparib
1.2.3 Talazoparib
1.3 Market by Application
1.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2016-2027)
2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Regions
2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Dynamic
2.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
2.3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
2.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
2.3.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue
3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue
3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio
3.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2020
3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served
3.6 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
3.7 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Type
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2022-2027)

5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2016-2027)
6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
6.2.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2027)
6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
6.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2027)
6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
6.4.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2016-2027)
7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
7.2.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2027)
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
7.3.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2027)
7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
7.4.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
8.2.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
8.3.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region
8.4.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2016-2027)
9.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
9.2.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
9.3.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
9.4.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type
10.2.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application
10.3.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country
10.4.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Clovis Oncology
11.5.1 Clovis Oncology Company Details
11.5.2 Clovis Oncology Business Overview
11.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.5.5 Clovis Oncology Recent Development
11.6 Everest Pharmaceuticals
11.6.1 Everest Pharmaceuticals Company Details
11.6.2 Everest Pharmaceuticals Business Overview
11.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
11.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
11.6.5 Everest Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Olaparib
Table 3. Key Players of Talazoparib
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2016-2021)
Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2022-2027)
Table 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends
Table 11. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers
Table 12. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges
Table 13. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints
Table 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2020)
Table 17. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
Table 21. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 64. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 69. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 74. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 79. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Clovis Oncology Company Details
Table 82. Clovis Oncology Business Overview
Table 83. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 84. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 85. Clovis Oncology Recent Development
Table 86. Everest Pharmaceuticals Company Details
Table 87. Everest Pharmaceuticals Business Overview
Table 88. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product
Table 89. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021) & (US$ Million)
Table 90. Everest Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Olaparib Features
Figure 3. Talazoparib Features
Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Ovarian Cancer Case Studies
Figure 6. Breast Cancer Case Studies
Figure 7. Other Case Studies
Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered
Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2022-2027)
Figure 13. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2020
Figure 14. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2020
Figure 15. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2020
Figure 16. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 17. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 18. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2016-2027)
Figure 20. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2016-2027)
Figure 21. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2016-2027)
Figure 22. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2016-2027)
Figure 26. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2016-2027)
Figure 27. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2016-2027)
Figure 28. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2016-2027)
Figure 36. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2016-2027)
Figure 37. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2016-2027)
Figure 38. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2016-2027)
Figure 46. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2016-2027)
Figure 47. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2016-2027)
Figure 48. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2016-2027)
Figure 52. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2016-2027)
Figure 53. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Country (2016-2027)
Figure 54. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 61. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 62. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場規模・現状・予測2021年-2027年] (Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027 / QY21JNE3934)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆